Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||1.51%||63.18||1.0%||$521.21m|
|VRTX||Vertex Pharmaceuticals, Inc.||3.02%||261.84||1.9%||$460.53m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.92%||667.56||2.6%||$410.61m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-1.41%||2.10||0.7%||$146.80m|
|EXAS||EXACT Sciences Corp.||7.04%||54.11||17.7%||$143.36m|
|BMRN||BioMarin Pharmaceutical, Inc.||2.33%||79.12||4.2%||$99.12m|
|TXG||10X Genomics, Inc.||6.83%||49.46||0.0%||$94.47m|
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.